Keyphrases
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Concurrent Chemoradiation
100%
Pneumonitis
100%
Immune Checkpoint Inhibitors
100%
Hazard Ratio
33%
Confidence Interval
33%
Chemoradiation
33%
Risk Factors
25%
Multivariable
25%
All-cause Mortality
16%
Interstitial Lung Disease
16%
Survivors
8%
Lung
8%
Cancer Cases
8%
Former Smokers
8%
Current Smokers
8%
Cox Proportional Hazards Model
8%
Multidisciplinary Team
8%
Radiation Dose
8%
Non-small Cell Lung Cancer Patients
8%
Curative Intent
8%
Increased Mortality
8%
Retrospective Chart Review
8%
Cumulative Incidence
8%
Scar
8%
Adjusted Model
8%
Mean Lung Dose
8%
Identify Risk
8%
Medical Experts
8%
Cause-specific Hazard Model
8%
Immune Checkpoint Therapy
8%
Durvalumab
8%
Medicine and Dentistry
Immunity
100%
Pneumonia
100%
Chemoradiotherapy
100%
Non Small Cell Lung Cancer
100%
Hazard Ratio
33%
Lung
16%
All Cause Mortality
16%
Interstitial Lung Disease
16%
Smoking
8%
Proportional Hazards Model
8%
Cumulative Incidence
8%
Scar Formation
8%
Durvalumab
8%
Immunology and Microbiology
Immunity
100%
Pneumonitis
100%
All Cause Mortality
16%
Scar Formation
8%
Durvalumab
8%